Beijing Tiantan Biological Products Co., Ltd.
600161
Rang in Aktien
#4320
Beijing Tiantan Biological Products Co., Ltd., established in 1998 and... Beijing Tiantan Biological Products Co., Ltd., established in 1998 and headquartered in Beijing, China, is actively involved in the full spectrum of blood product operations within China. This includes pioneering research and development, manufacturing, sales, and providing consultancy services. Its comprehensive product line features critical blood-derived medicines such as intravenous immunoglobulin, human albumin, and various specialized human immunoglobulins for conditions like hepatitis B (both standard and freeze-dried formulations) and tetanus, alongside other general human immunoglobulin preparations and intravenous blood system solutions. The company operates as a subsidiary of China National Biotec Group Company Limited.
Aktienkurs
$1.81
Marktkapitalisierung
$3.59B
Veränderung (1 Tag)
-0.90%
Veränderung (1 Jahr)
-32.39%
Land
CN
Handel Beijing Tiantan Biological Products Co., Ltd. (600161)
Kategorie
Healthcare
Gewinn für Beijing Tiantan Biological Products Co., Ltd. (600161)
Gewinn im 2026 TTM: 0
Laut den aktuellen Finanzberichten von Beijing Tiantan Biological Products Co., Ltd. betragen die aktuellen Gewinne des Unternehmens 0. Im Jahr 2026 erzielte das Unternehmen einen Gewinn von 0, gleich wie dem Gewinn im Jahr 2026, der 0 betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Beijing Tiantan Biological Products Co., Ltd. von 2001 bis 2026
Gewinn am Ende jedes Jahres
| Jahr | Gewinn | ändert |
|---|---|---|
| 2025 | $260.52M | -25.35% |
| 2024 | $348.98M | 37.34% |
| 2023 | $254.09M | 22.89% |
| 2022 | $206.77M | 5.90% |
| 2021 | $195.25M | 15.45% |
| 2020 | $169.13M | 12.87% |
| 2019 | $149.85M | 18.76% |
| 2018 | $126.18M | -46.94% |
| 2017 | $237.80M | 345.91% |
| 2016 | $53.33M | 74.97% |
| 2015 | $30.48M | -37.81% |
| 2014 | $49.01M | -45.63% |
| 2013 | $90.14M | 26.29% |
| 2012 | $71.38M | 31.58% |
| 2011 | $54.25M | 32.45% |
| 2010 | $40.96M | -20.34% |
| 2009 | $51.42M | 51.23% |
| 2008 | $34.00M | 38.09% |
| 2007 | $24.62M | 53.52% |
| 2006 | $16.04M | 54.94% |
| 2005 | $10.35M | 53.69% |
| 2004 | $6.73M | 8.91% |
| 2003 | $6.18M | 14.01% |
| 2002 | $5.42M | 10.09% |
| 2001 | $4.93M | 0.00% |
Gewinn ähnlicher Unternehmen oder Konkurrenten
| Unternehmen | Gewinn | Gewinnunterschied | Land |
|---|---|---|---|
| $5.27B | - |
US
|
|
| $-3.09B | - |
US
|
|
| $-4.02B | - |
AU
|
|
| $1.95B | - |
NL
|
|
| - | - |
CH
|
